Navigation Links
Innovia Receives FDA Clearance For The InnoPort(TM)
Date:6/2/2009

New medical device will facilitate single port access laparoscopic surgery

MIAMI, June 2 /PRNewswire/ -- Innovia LLC, a privately held biomaterials-based medical device company, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market the InnoPort(TM) to facilitate single port access laparoscopy.

The InnoPort is inserted into the abdomen to perform laparoscopic surgery through one small incision--instead of multiple incisions--with the goal of minimizing scarring, pain, recovery time, and complication risk to the patient. The port is enabled by Quatromer(R), one of Innovia's proprietary biopolymers. The biopolymer's patented flexibility grants the physician unrestricted access to the abdominal cavity with up to three rigid and/or articulating instruments.

"In the time-sensitive and no-nonsense environment of the OR, the bell-and-whistle features of existing ports were overly complicated and tended to slow down my procedures. I needed a port that was simple and reliable, and this was the inspiration for the InnoPort," said David Edelman, MD, General Surgeon and inventor of the device. "Compared to other available single access ports, the InnoPort seems to be the easiest to use. The one-piece, stopper-shaped device can be inserted quickly, and its flexibility allows me to manipulate my instruments to extreme angulations without crowding one another in the working space, all while maintaining a tight insufflation seal."

"Our staff is especially proud to have worked with Dr. Edelman to develop the InnoPort," adds Len Pinchuk, Ph.D., D.Sc., President/CEO of Innovia. "We believe that the device will fulfill unmet clinical needs for simplicity and efficacy in the rapidly expanding single incision laparoscopic space and are confident that physicians will agree."

The InnoPort is scheduled for commercialization in the United States this year with expansion to Europe thereafter. For further information, please contact Innovia.

ABOUT INNOVIA LLC

Innovia is a privately held biomaterials-based medical device company that specializes in the development of innovative medical devices incorporating proprietary novel biomaterials. Innovia's experienced and highly specialized engineers, scientists, and chemists have been responsible for over $15 billion in revenue throughout their careers in the medical device industry. Please visit www.innovia-llc.com to learn more about the Company.


'/>"/>
SOURCE Innovia LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cordex Receives Special Protocol Assessment Approval from FDA for ATPace(TM)
2. Respected Surgeon Receives Emmy Nomination
3. Edward Diehl Receives Outstanding Achievement Award From the American College of Addiction Treatment Administrators (ACATA)
4. LA BioMed researcher receives clinical teaching award
5. SAFC Pharmas St. Louis HPAPI Conjugates Facility Receives SafeBridge Certification
6. ALIMTA(R) (pemetrexed for injection) Receives Positive Opinion From CHMP as Maintenance Therapy for Nonsquamous Non-Small Cell Lung Cancer
7. Bausch & Lomb Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis (Pink Eye)
8. Family Health International Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research Project Led by David Sokal, M.D.
9. Dalcon Receives Unified Communications Magazines Product of the Year Award
10. InfuSystem Receives Accreditation from the Community Health Accreditation Program (CHAP)
11. Childrens Health Fund Receives $500,000 from the Starr International Foundation to Support South Bronx Homeless Health Care Clinic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... 20, 2017 , ... Vitamin Well has launched two new ... have been produced in collaboration with Zlatan Ibrahimovic and have been developed to ... a successful launch in Sweden last year, the next generation sports drinks VW+001 ...
(Date:1/20/2017)... ... 20, 2017 , ... “Code Word: Chocolate Biscuit”: a biographical account following a man who went ... creation of published author, Marlyn Ivey, born in Lynn Haven, Florida and at the age ... at 19 years of age, he joined the Navy and got married right out of ...
(Date:1/20/2017)... , ... January 20, 2017 , ... “Christmas in Suffolk”: ... of published author, Sara Seymour, who lives in Lafayette, Indiana where she works in ... on iced coffees and writes. , Published by Christian Faith Publishing, Sara Seymour’s new ...
(Date:1/20/2017)... ... ... Land of More and More”: a brilliant story for children and adults alike ... achievable answer. “The Land of More and More” is the creation of published author, ... where he works with the children’s ministry department. , Michael says that he ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... an On-demand E-learning system for Clinical and Regulatory education for Physicians, Physician ... on Aerolib`s successful education methodology of Disease Specific Documentation Improvement. , The ...
Breaking Medicine News(10 mins):
(Date:1/20/2017)... , Jan. 20, 2017  Palladian Health, ... has announced the launch of an opioid management ... guidelines on opioids and helps stem the growing ... often prescribed to treat chronic non-cancer pain (back ... serious risks and lack of evidence regarding long-term ...
(Date:1/19/2017)... 2017 The global immunomodulators market is ... according to a new study by Grand View ... predominantly driven by high R&D investments employed by ... of new and therapeutically advanced drugs. This is ... an unprecedented rate into the immunomodulators market hence ...
(Date:1/19/2017)... 19, 2017 Report Details ... Alzheimer,s Disease ... Companies – our new study reveals trends, R&D progress, ... events affecting the Alzheimer,s disease therapeutics and diagnostics market. ... key questions: - How is the Alzheimer,s disease therapeutics ...
Breaking Medicine Technology: